Bath & Body Works (NYSE:BBWI) Trading Down 5% – Time to Sell?

Bath & Body Works, Inc. (NYSE:BBWI)’s stock price was down 5% during mid-day trading on Monday . The stock traded as low as $18.51 and last traded at $18.4320. Approximately 2,669,584 shares traded hands during trading, a decline of 49% from the average daily volume of 5,226,206 shares. The stock had previously closed at $19.41.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on BBWI shares. UBS Group upped their target price on Bath & Body Works from $21.00 to $22.00 and gave the company a “neutral” rating in a research note on Monday, February 23rd. Deutsche Bank Aktiengesellschaft boosted their price objective on Bath & Body Works from $21.00 to $22.00 and gave the company a “hold” rating in a report on Tuesday, March 3rd. Barclays upped their price objective on Bath & Body Works from $20.00 to $21.00 and gave the company an “equal weight” rating in a research report on Monday, March 2nd. Guggenheim started coverage on Bath & Body Works in a research note on Tuesday, December 9th. They issued a “neutral” rating on the stock. Finally, Robert W. Baird set a $20.00 target price on Bath & Body Works in a research report on Wednesday, December 17th. Three investment analysts have rated the stock with a Buy rating and fourteen have given a Hold rating to the company. According to data from MarketBeat.com, Bath & Body Works has a consensus rating of “Hold” and a consensus target price of $24.00.

Bath & Body Works Trading Down 1.0%

The firm has a market capitalization of $3.60 billion, a P/E ratio of 5.68, a price-to-earnings-growth ratio of 1.86 and a beta of 1.48. The stock has a 50-day simple moving average of $21.99 and a two-hundred day simple moving average of $22.53.

Bath & Body Works (NYSE:BBWI) last posted its quarterly earnings results on Wednesday, March 4th. The company reported $2.05 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.77 by $0.28. The business had revenue of $2.72 billion for the quarter, compared to the consensus estimate of $2.59 billion. Bath & Body Works had a negative return on equity of 45.60% and a net margin of 8.90%.The business’s revenue was down 2.3% compared to the same quarter last year. During the same quarter in the prior year, the company earned $2.09 EPS. Bath & Body Works has set its Q1 2026 guidance at 0.240-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. As a group, research analysts expect that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, March 6th. Shareholders of record on Friday, February 20th were issued a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a yield of 4.5%. The ex-dividend date was Friday, February 20th. Bath & Body Works’s dividend payout ratio is presently 25.40%.

Institutional Investors Weigh In On Bath & Body Works

Several large investors have recently modified their holdings of the business. Retirement Systems of Alabama increased its holdings in shares of Bath & Body Works by 40.6% in the 3rd quarter. Retirement Systems of Alabama now owns 772,324 shares of the company’s stock valued at $19,895,000 after acquiring an additional 223,089 shares during the period. Allianz Asset Management GmbH lifted its stake in shares of Bath & Body Works by 58.8% during the 3rd quarter. Allianz Asset Management GmbH now owns 263,628 shares of the company’s stock worth $6,791,000 after purchasing an additional 97,640 shares during the last quarter. Diamond Hill Capital Management Inc. lifted its stake in shares of Bath & Body Works by 29.9% during the 3rd quarter. Diamond Hill Capital Management Inc. now owns 369,452 shares of the company’s stock worth $9,517,000 after purchasing an additional 85,000 shares during the last quarter. JPMorgan Chase & Co. boosted its position in Bath & Body Works by 11.5% during the second quarter. JPMorgan Chase & Co. now owns 7,080,106 shares of the company’s stock valued at $212,120,000 after purchasing an additional 733,000 shares in the last quarter. Finally, Access Investment Management LLC bought a new stake in Bath & Body Works during the third quarter valued at about $3,506,000. Institutional investors own 95.14% of the company’s stock.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.